| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.886 | 0.003 | 0.886 | Acetylcholinesterase inhibitor | 0.839 0.003 DBMET02730 | ||
| 0.865 | 0.003 | 0.865 | Cholinergic | 0.823 0.003 DBMET02730 | ||
| 0.667 | 0.005 | 0.712 | Amyloid beta aggregation inhibitor | 0.712 0.005 DBMET02730 | DBMET02730 | |
| 0.655 | 0.004 | 0.655 | Butyrylcholinesterase inhibitor | 0.612 0.004 DBMET02730 | ||
| 0.484 | 0.017 | 0.588 | Antiamyloidogenic | 0.588 0.009 DBMET02730 | DBMET02730 | |
| 0.415 | 0.051 | 0.448 | Vasodilator, peripheral | 0.448 0.041 DBMET02730 | DBMET02730 | |
| 0.408 | 0.044 | 0.408 | 5 Hydroxytryptamine release stimulant | 0.334 0.06 DBMET02730 | ||
| 0.394 | 0.04 | 0.394 | Nootropic | 0.302 0.073 DBMET02730 | ||
| 0.348 | 0.011 | 0.348 | 5 Hydroxytryptamine 2B antagonist | 0.227 0.022 DBMET02730 | ||
| 0.377 | 0.051 | 0.42 | Caspase 3 stimulant | 0.42 0.038 DBMET02730 | DBMET02730 | |
| 0.336 | 0.015 | 0.336 | 5 Hydroxytryptamine antagonist | 0.172 0.041 DBMET02730 | ||
| 0.41 | 0.105 | 0.471 | Caspase 9 stimulant | 0.471 0.072 DBMET02730 | DBMET02730 | |
| 0.314 | 0.011 | 0.319 | Dopamine antagonist | 0.319 0.011 DBMET02730 | DBMET02730 | |
| 0.287 | 0.006 | 0.287 | Sigma receptor antagonist | 0.177 0.009 DBMET02730 | ||
| 0.307 | 0.028 | 0.307 | P-glycoprotein inhibitor | 0.292 0.03 DBMET02730 | ||
| 0.266 | 0.008 | 0.266 | Alpha 2c adrenoreceptor antagonist | 0.244 0.011 DBMET02730 | ||
| 0.291 | 0.045 | 0.291 | Psychostimulant | 0.282 0.048 DBMET02730 | ||
| 0.247 | 0.02 | 0.247 | Alpha adrenoreceptor antagonist | 0.214 0.025 DBMET02730 | ||
| 0.238 | 0.012 | 0.238 | Alpha 2 adrenoreceptor antagonist | 0.234 0.013 DBMET02730 | ||
| 0.297 | 0.071 | 0.353 | Spasmolytic | 0.353 0.052 DBMET02730 | DBMET02730 | |
| 0.234 | 0.014 | 0.238 | Dopamine D2 antagonist | 0.238 0.014 DBMET02730 | DBMET02730 | |
| 0.224 | 0.025 | 0.224 | 5 Hydroxytryptamine 2 antagonist | 0.13 0.053 DBMET02730 | ||
| 0.216 | 0.019 | 0.216 | Alpha 1 adrenoreceptor antagonist | 0.166 0.026 DBMET02730 | ||
| 0.209 | 0.022 | 0.209 | Alpha 2b adrenoreceptor antagonist | 0.186 0.027 DBMET02730 | ||
| 0.197 | 0.015 | 0.197 | 5 Hydroxytryptamine 1A antagonist | 0.114 0.027 DBMET02730 | ||
| 0.197 | 0.014 | 0.211 | Alpha 2a adrenoreceptor antagonist | 0.211 0.013 DBMET02730 | DBMET02730 | |
| 0.186 | 0.006 | 0.186 | Interleukin 5 antagonist | 0.171 0.008 DBMET02730 | ||
| 0.191 | 0.013 | 0.191 | Dopamine D4 antagonist | 0.151 0.017 DBMET02730 | ||
| 0.191 | 0.017 | 0.191 | Alpha 1a adrenoreceptor antagonist | 0.132 0.027 DBMET02730 | ||
| 0.171 | 0.008 | 0.171 | NMDA 2B receptor antagonist | 0.167 0.008 DBMET02730 | ||
| 0.178 | 0.019 | 0.178 | 5 Hydroxytryptamine 1 antagonist | 0.094 0.039 DBMET02730 | ||
| 0.168 | 0.013 | 0.286 | Dopamine D1 antagonist | 0.286 0.006 DBMET02730 | DBMET02730 | |
| 0.204 | 0.06 | 0.204 | Sigma receptor agonist | 0.163 0.077 DBMET02730 | ||
| 0.29 | 0.149 | 0.29 | Analgesic | 0.24 0.192 DBMET02730 | ||
| 0.233 | 0.092 | 0.253 | Interleukin agonist | 0.253 0.077 DBMET02730 | DBMET02730 | |
| 0.158 | 0.02 | 0.158 | Alpha 1b adrenoreceptor antagonist | 0.122 0.029 DBMET02730 | ||
| 0.147 | 0.013 | 0.155 | Aromatase inhibitor | 0.155 0.012 DBMET02730 | DBMET02730 | |
| 0.132 | 0.004 | 0.189 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.189 0.003 DBMET02730 | DBMET02730 | |
| 0.146 | 0.019 | 0.146 | Acetylcholine release stimulant | 0.112 0.061 DBMET02730 | ||
| 0.151 | 0.026 | 0.151 | 5 Hydroxytryptamine 2C antagonist | 0.087 0.055 DBMET02730 | ||
| 0.142 | 0.018 | 0.142 | Alpha adrenoreceptor agonist | 0.142 0.018 DBMET02730 | ||
| 0.125 | 0.003 | 0.125 | CYP24 inhibitor | 0.099 0.003 DBMET02730 | ||
| 0.149 | 0.028 | 0.149 | 5 Hydroxytryptamine 2A antagonist | 0.079 0.06 DBMET02730 | ||
| 0.122 | 0.01 | 0.122 | Alpha 2 adrenoreceptor agonist | 0.117 0.01 DBMET02730 | ||
| 0.168 | 0.056 | 0.217 | Protein kinase stimulant | 0.217 0.036 DBMET02730 | DBMET02730 | |
| 0.12 | 0.009 | 0.12 | CC chemokine 5 receptor agonist | 0.117 0.009 DBMET02730 | ||
| 0.147 | 0.046 | 0.147 | Acetylcholine muscarinic antagonist | 0.144 0.048 DBMET02730 | ||
| 0.118 | 0.019 | 0.118 | Alpha 1d adrenoreceptor antagonist | 0.069 0.035 DBMET02730 | ||
| 0.213 | 0.116 | 0.213 | 5 Hydroxytryptamine 1E antagonist | 0.19 0.142 DBMET02730 | ||
| 0.171 | 0.075 | 0.171 | Tumour necrosis factor antagonist | 0.153 0.097 DBMET02730 | ||
| 0.161 | 0.065 | 0.164 | Acetylcholine M1 receptor antagonist | 0.164 0.063 DBMET02730 | DBMET02730 | |
| 0.109 | 0.015 | 0.109 | Acetylcholine M5 receptor agonist | |||
| 0.152 | 0.062 | 0.152 | Toll-Like receptor 9 antagonist | 0.106 0.103 DBMET02730 | ||
| 0.188 | 0.098 | 0.188 | HERG channel blocker | |||
| 0.127 | 0.038 | 0.127 | Electron transport complex I inhibitor | 0.125 0.041 DBMET02730 | ||
| 0.276 | 0.19 | 0.378 | Apoptosis agonist | 0.378 0.125 DBMET02730 | DBMET02730 | |
| 0.189 | 0.103 | 0.189 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.143 | 0.057 | 0.143 | Cholinergic antagonist | 0.129 0.066 DBMET02730 | ||
| 0.234 | 0.15 | 0.252 | Vasodilator, coronary | 0.252 0.132 DBMET02730 | DBMET02730 | |
| 0.137 | 0.058 | 0.137 | Acetylcholine antagonist | 0.124 0.067 DBMET02730 | ||
| 0.086 | 0.006 | 0.088 | Ryanodine receptor antagonist | 0.088 0.005 DBMET02730 | DBMET02730 | |
| 0.084 | 0.005 | 0.084 | Sigma 2 receptor antagonist | 0.062 0.007 DBMET02730 | ||
| 0.142 | 0.064 | 0.142 | Nav1.6 sodium channel blocker | |||
| 0.088 | 0.01 | 0.088 | Calcium channel P-type blocker | 0.07 0.028 DBMET02730 | ||
| 0.142 | 0.066 | 0.155 | Neurotrophic factor | 0.155 0.055 DBMET02730 | DBMET02730 | |
| 0.223 | 0.147 | 0.223 | Ca(v)3.3 blocker | |||
| 0.085 | 0.011 | 0.085 | 5 Hydroxytryptamine 4 antagonist | 0.063 0.021 DBMET02730 | ||
| 0.118 | 0.044 | 0.118 | Antihistaminic | |||
| 0.211 | 0.139 | 0.328 | 12-Lipoxygenase inhibitor | 0.328 0.066 DBMET02730 | DBMET02730 | |
| 0.098 | 0.027 | 0.098 | 5 Hydroxytryptamine uptake inhibitor | 0.056 0.05 DBMET02730 | ||
| 0.108 | 0.037 | 0.108 | Histamine H1 receptor antagonist | |||
| 0.226 | 0.155 | 0.276 | Sodium/bile acid cotransporter inhibitor | 0.276 0.102 DBMET02730 | DBMET02730 | |
| 0.111 | 0.05 | 0.111 | Antiadrenergic | 0.108 0.051 DBMET02730 | ||
| 0.106 | 0.045 | 0.106 | Histamine antagonist | |||
| 0.177 | 0.117 | 0.343 | Free radical scavenger | 0.343 0.041 DBMET02730 | DBMET02730 | |
| 0.108 | 0.049 | 0.108 | Adrenaline antagonist | 0.105 0.051 DBMET02730 | ||
| 0.089 | 0.032 | 0.126 | Dopamine agonist | 0.126 0.019 DBMET02730 | DBMET02730 | |
| 0.088 | 0.036 | 0.088 | Viral attachment inhibitor | 0.078 0.053 DBMET02730 | ||
| 0.161 | 0.108 | 0.216 | DNA methylase inhibitor | 0.216 0.069 DBMET02730 | DBMET02730 | |
| 0.195 | 0.145 | 0.238 | Tyrosine 3 hydroxylase inhibitor | 0.238 0.08 DBMET02730 | DBMET02730 | |
| 0.171 | 0.122 | 0.309 | Aldehyde oxidase inhibitor | 0.309 0.064 DBMET02730 | DBMET02730 | |
| 0.066 | 0.017 | 0.136 | Estradiol 17 beta-dehydrogenase inhibitor | 0.136 0.007 DBMET02730 | DBMET02730 | |
| 0.098 | 0.051 | 0.098 | Alpha 2d adrenoreceptor antagonist | 0.086 0.082 DBMET02730 | ||
| 0.078 | 0.035 | 0.078 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.053 | 0.01 | 0.053 | Sigma 1 receptor antagonist | 0.032 0.016 DBMET02730 | ||
| 0.095 | 0.052 | 0.095 | Calcium antagonist | |||
| 0.065 | 0.023 | 0.065 | Chemokine receptor agonist | |||
| 0.083 | 0.042 | 0.106 | NMDA 2 receptor antagonist | 0.106 0.029 DBMET02730 | DBMET02730 | |
| 0.142 | 0.104 | 0.142 | Antipruritic | |||
| 0.052 | 0.015 | 0.052 | Glutamate (mGluR group II) antagonist | 0.038 0.027 DBMET02730 | ||
| 0.099 | 0.064 | 0.099 | Chemokine receptor antagonist | |||
| 0.083 | 0.049 | 0.083 | CC chemokine receptor antagonist | |||
| 0.048 | 0.014 | 0.048 | Tryptase inhibitor | 0.04 0.022 DBMET02730 | ||
| 0.061 | 0.026 | 0.061 | Dopamine D4 agonist | 0.049 0.036 DBMET02730 | ||
| 0.193 | 0.16 | 0.26 | Hypoxia-inducible factor 1 alpha inhibitor | 0.26 0.092 DBMET02730 | DBMET02730 | |
| 0.131 | 0.098 | 0.131 | Neuropeptide Y1 antagonist | |||
| 0.07 | 0.037 | 0.07 | 5 Hydroxytryptamine 2A agonist | |||
| 0.097 | 0.066 | 0.097 | Glutamate (mGluR7) agonist | |||
| 0.053 | 0.022 | 0.054 | Opioid kappa receptor agonist | 0.054 0.022 DBMET02730 | DBMET02730 | |
| 0.204 | 0.173 | 0.233 | Antithrombotic | 0.233 0.141 DBMET02730 | DBMET02730 | |
| 0.058 | 0.028 | 0.058 | CC chemokine 5 receptor antagonist | |||
| 0.162 | 0.133 | 0.177 | Cyclic AMP phosphodiesterase inhibitor | 0.177 0.115 DBMET02730 | DBMET02730 | |
| 0.073 | 0.046 | 0.073 | Phosphodiesterase VIII inhibitor | |||
| 0.066 | 0.04 | 0.066 | Acetylcholine M2 receptor antagonist | |||
| 0.046 | 0.02 | 0.046 | Heme oxygenase inhibitor | 0.041 0.036 DBMET02730 | ||
| 0.102 | 0.075 | 0.176 | Chelator | 0.176 0.029 DBMET02730 | DBMET02730 | |
| 0.062 | 0.036 | 0.062 | Dopamine uptake inhibitor | |||
| 0.076 | 0.05 | 0.076 | Acetylcholine M4 receptor antagonist | |||
| 0.038 | 0.013 | 0.038 | Glutamate (mGluR2) antagonist | 0.027 0.026 DBMET02730 | ||
| 0.056 | 0.033 | 0.056 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.111 | 0.089 | 0.15 | Tubulin antagonist | 0.15 0.058 DBMET02730 | DBMET02730 | |
| 0.07 | 0.049 | 0.07 | Amidase inhibitor | 0.063 0.061 DBMET02730 | ||
| 0.115 | 0.095 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.059 DBMET02730 | DBMET02730 | |
| 0.058 | 0.039 | 0.058 | Alpha 1 adrenoreceptor agonist | 0.051 0.048 DBMET02730 | ||
| 0.143 | 0.126 | 0.154 | Non-steroidal antiinflammatory agent | 0.154 0.109 DBMET02730 | DBMET02730 | |
| 0.055 | 0.04 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.077 | 0.062 | 0.086 | Opioid kappa receptor antagonist | 0.086 0.05 DBMET02730 | DBMET02730 | |
| 0.072 | 0.059 | 0.077 | Analgesic, opioid | 0.077 0.052 DBMET02730 | DBMET02730 | |
| 0.21 | 0.198 | 0.21 | Calcium channel activator | |||
| 0.049 | 0.037 | 0.053 | Thromboxane A2 antagonist | 0.053 0.034 DBMET02730 | DBMET02730 | |
| 0.058 | 0.046 | 0.058 | Dopamine D3 antagonist | |||
| 0.15 | 0.139 | 0.199 | Neurotrophic factor enhancer | 0.199 0.077 DBMET02730 | DBMET02730 | |
| 0.042 | 0.032 | 0.042 | Histamine H3 receptor antagonist | |||
| 0.05 | 0.041 | 0.053 | Thromboxane antagonist | 0.053 0.038 DBMET02730 | DBMET02730 | |
| 0.014 | 0.005 | 0.014 | Melatonin 2 antagonist | |||
| 0.136 | 0.129 | 0.153 | ATPase inhibitor | 0.153 0.096 DBMET02730 | DBMET02730 | |
| 0.081 | 0.076 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.095 0.047 DBMET02730 | DBMET02730 | |
| 0.096 | 0.093 | 0.122 | Cholesterol synthesis inhibitor | 0.122 0.064 DBMET02730 | DBMET02730 | |
| 0.034 | 0.033 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.039 | 0.038 | 0.039 | Liver X receptor agonist | |||
| 0.056 | 0.056 | 0.063 | Bcl-xL inhibitor | 0.063 0.033 DBMET02730 | DBMET02730 | |
| 0.13 | 0.13 | 0.175 | DNA methyltransferase I inhibitor | 0.175 0.083 DBMET02730 | DBMET02730 | |
| 0.116 | 0.122 | 0.163 | Heat shock protein 90 antagonist | 0.163 0.062 DBMET02730 | DBMET02730 | |
| 0.122 | 0.13 | 0.157 | Melanin inhibitor | 0.157 0.073 DBMET02730 | DBMET02730 | |
| 0.153 | 0.162 | 0.293 | Antioxidant | 0.293 0.064 DBMET02730 | DBMET02730 | |
| 0.181 | 0.194 | 0.198 | 5 Hydroxytryptamine uptake stimulant | 0.198 0.155 DBMET02730 | DBMET02730 | |
| 0.126 | 0.14 | 0.173 | Hepatoprotectant | 0.173 0.086 DBMET02730 | DBMET02730 | |
| 0.043 | 0.058 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.038 DBMET02730 | DBMET02730 | |
| 0.066 | 0.081 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.04 DBMET02730 | DBMET02730 | |
| 0.068 | 0.088 | 0.079 | Opioid antagonist | 0.079 0.07 DBMET02730 | DBMET02730 | |
| 0.122 | 0.142 | 0.145 | Interleukin 6 antagonist | 0.145 0.096 DBMET02730 | DBMET02730 | |
| 0.118 | 0.14 | 0.163 | Nitric oxide antagonist | 0.163 0.086 DBMET02730 | DBMET02730 | |
| 0.105 | 0.129 | 0.125 | Vanilloid 1 agonist | 0.125 0.075 DBMET02730 | DBMET02730 | |
| 0.093 | 0.117 | 0.123 | Estrogen antagonist | 0.123 0.049 DBMET02730 | DBMET02730 | |
| 0.038 | 0.063 | 0.061 | Alpha tubulin antagonist | 0.061 0.03 DBMET02730 | DBMET02730 | |
| 0.064 | 0.091 | 0.081 | NMDA receptor antagonist | 0.081 0.064 DBMET02730 | DBMET02730 | |
| 0.109 | 0.143 | 0.13 | Arachidonic acid antagonist | 0.13 0.113 DBMET02730 | DBMET02730 | |
| 0.08 | 0.121 | 0.155 | Amylase inhibitor | 0.155 0.061 DBMET02730 | DBMET02730 | |
| 0.032 | 0.072 | 0.066 | Beta tubulin antagonist | 0.066 0.036 DBMET02730 | DBMET02730 | |
| 0.025 | 0.065 | 0.051 | Estrogen agonist | 0.051 0.035 DBMET02730 | DBMET02730 | |
| 0.074 | 0.118 | 0.125 | Cystathionine beta-synthase inhibitor | 0.125 0.055 DBMET02730 | DBMET02730 | |
| 0.151 | 0.196 | 0.182 | RNA-directed DNA polymerase inhibitor | 0.182 0.129 DBMET02730 | DBMET02730 | |
| 0.044 | 0.089 | 0.062 | Heat shock protein 90 beta antagonist | 0.062 0.037 DBMET02730 | DBMET02730 | |
| 0.21 | 0.257 | 0.257 | Calcium channel L-type activator | 0.257 0.197 DBMET02730 | DBMET02730 | |
| 0.047 | 0.1 | 0.072 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.072 0.059 DBMET02730 | DBMET02730 | |
| 0.062 | 0.116 | 0.088 | HIV-1 integrase (Overall Integration) inhibitor | 0.088 0.067 DBMET02730 | DBMET02730 | |
| 0.017 | 0.073 | 0.041 | Catechol O-methyltransferase inhibitor | 0.041 0.013 DBMET02730 | DBMET02730 | |
| 0.084 | 0.145 | 0.118 | NADPH oxidase inhibitor | 0.118 0.086 DBMET02730 | DBMET02730 | |
| 0.104 | 0.167 | 0.133 | Adenylate cyclase stimulant | 0.133 0.096 DBMET02730 | DBMET02730 | |
| 0.051 | 0.118 | 0.081 | Adrenaline agonist | 0.081 0.057 DBMET02730 | DBMET02730 | |
| 0.064 | 0.138 | 0.105 | Estrogen receptor beta antagonist | 0.105 0.054 DBMET02730 | DBMET02730 | |
| 0.058 | 0.149 | 0.104 | Topoisomerase II inhibitor | 0.104 0.082 DBMET02730 | DBMET02730 | |
| 0.127 | 0.232 | 0.17 | Superoxide dismutase inhibitor | 0.17 0.155 DBMET02730 | DBMET02730 | |
| 0.071 | 0.177 | 0.106 | Toll-Like receptor 2 antagonist | 0.106 0.095 DBMET02730 | DBMET02730 | |
| 0.042 | 0.149 | 0.079 | HIV-1 integrase inhibitor | 0.079 0.038 DBMET02730 | DBMET02730 | |
| 0.023 | 0.137 | 0.057 | HIV-1 integrase (Strand Transfer) inhibitor | 0.057 0.044 DBMET02730 | DBMET02730 | |
| 0.041 | 0.158 | 0.089 | Monophenol monooxygenase inhibitor | 0.089 0.084 DBMET02730 | DBMET02730 | |
| 0.123 | 0.242 | 0.217 | Lipoxygenase inhibitor | 0.217 0.124 DBMET02730 | DBMET02730 | |
| 0.058 | 0.188 | 0.08 | Vanilloid agonist | 0.08 0.07 DBMET02730 | DBMET02730 | |
| 0.024 | 0.175 | 0.06 | HIV-1 integrase (3'-Processing) inhibitor | 0.06 0.047 DBMET02730 | DBMET02730 | |
| 0.043 | 0.268 | 0.126 | Lipid peroxidase inhibitor | 0.126 0.087 DBMET02730 | DBMET02730 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |